X0306 4 2019-09-09 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001726096 Daniell Richard C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 0 1 0 0 Exec. VP, European Commercial Ordinary Shares 2019-09-09 4 M 0 696 A 696 D Ordinary Shares 2019-09-09 4 S 0 333 7.16 D 363 D Restricted Share Units 2019-09-09 4 M 0 696 0.00 D Ordinary Shares 696 698 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. Restricted share units were granted on September 9, 2016, with 696 vesting on each of September 9, 2018 and September 9, 2019 and 698 vesting on September 9, 2020. /s/ Dov Bergwerk, as attorney-in-fact for Richard Daniell 2019-09-11